Gujarat Kidney And Super Speciality Limited (NSE:GKSL)
India · Delayed Price · Currency is INR 153.00
-3.25 (-2.08%)
At close: Aug 21, 2026
NSE:GKSL Revenue
Gujarat Kidney And Super Speciality had revenue of 349.78M INR in the quarter ending June 30, 2026, with 129.21% growth. This brings the company's revenue in the last twelve months to 1.02B, up 120.34% year-over-year. In the fiscal year ending March 31, 2026, Gujarat Kidney And Super Speciality had annual revenue of 820.13M with 103.80% growth.
Revenue (ttm)
1.02B
Revenue Growth
+120.34%
P/S Ratio
11.94
Revenue / Employee
n/a
Employees
n/a
Market Cap
12.06B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 820.13M | 417.71M | 103.80% |
| Mar 31, 2025 | 402.42M | 354.68M | 742.89% |
| Mar 31, 2024 | 47.74M | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | 7.86M | -3.17M | -28.71% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Kovai Medical Center and Hospital | 16.43B |
| KMC Speciality Hospitals (India) | 3.31B |
| Asarfi Hospital | 1.85B |
| KRM Ayurveda | 1.09B |
| Nephro Care India | 1.01B |
| Hannah Joseph Hospital | 920.52M |
| Shanmuga Hospital | 483.94M |
| Sharma East India Hospitals & Medical Research | 372.24M |